Alerts will be sent to your verified email
Verify EmailKAPILCO
|
Skybiotech Healthcar
|
Spenta Intl.
|
KSL & Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.54 % | 4.1 % | 16.99 % |
|
5yr average Equity Multiplier
|
1.38 | 2.08 | -0.95 |
|
5yr Average Asset Turnover Ratio
|
0.09 | 0.74 | 0.12 |
|
5yr Avg Net Profit Margin
|
-8.4 % | 0.99 % | -13284.23 % |
|
Price to Book
|
3.1 | 1.01 | 0.0 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
41.6 Days | 171.35 Days | 120.27 Days |
|
Inventory Days
|
20.62 Days | 121.92 Days | 55.39 Days |
|
Days Receivable
|
21.98 Days | 84.61 Days | 0.0 |
|
Days Payable
|
15.71 Days | 52.63 Days | 25.31 Days |
|
5yr Average Interest Coverage Ratio
|
-50.28 | 1.57 | -0.37 |
|
5yr Avg ROCE
|
0.32 % | 8.43 % | -25.76 % |
|
5yr Avg Operating Profit Margin
|
-7.99 % | 6.58 % | -1974.42 % |
|
5 yr average Debt to Equity
|
0.2 | 0.78 | -1.61 |
|
5yr CAGR Net Profit
|
126.22 % | n/a | -15.08 % |
|
5yr Average Return on Assets
|
-0.02 % | 1.35 % | -17.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.48 % | 64.71 % | 39.22 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.69 % | 0.23 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Skybiotech Healthcar
|
Spenta Intl.
|
KSL & Industries
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|